Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy.

The research article evaluates the potential of a sequence-based antigenic distance measure, known as p(epitope) value, to predict the efficacy of equine influenza vaccine strains.

Overview of the Study

• This study primarily focused on examining the effectiveness of a sequence-based antigenic distance measure, known as p(epitope) value, initially developed for human influenza, for its potential applicability to equine influenza vaccine strain selection.
• Antigenic distance can be defined as a measure of the genetic difference between strains of a virus.
• The model considered pairs of vaccine and challenge strains used in cross-protection studies on ponies.

Study Findings

• The research displayed a negative correlation between the p(epitope) value and vaccine effectiveness, which suggests the p(epitope) value might provide valuable insights on the efficacy of equine influenza vaccine strains.
• However, for the correlation to reach statistical significance (a p-value less than or equal to 0.05), one pair of strains had to be excluded from the analysis.

Implications and Future Directions

• Given the results, the researchers suggest that the p(epitope) value could provide additional data to consider when deciding on the necessary updates for equine influenza vaccine strains.
• However, they also assert the need for further research to define the epitopes—the parts of an antigen that are recognized by the immune system—of the equine H3N8 haemagglutinin protein recognised by equine antibodies. This could lead to enhancement of the p(epitope) value calculation.
• The study also acknowledges that factors like vaccine potency and virulence of currently circulating strains may also significantly affect the efficacy of vaccinations. Thus, these factors should also be taken into account in future research.